VRBPAC Virtual Meeting: FDA’s ‘Future Framework’ — June 28

Topic: The committee will meet in open session to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified

Dr. Meryl Nass will be providing live blogging on this meeting.